Hca (HCA) Stock
Large private hospital operator providing comprehensive patient care. Here's the price, business snapshot, and what's worth knowing about Hca in October 2026.
HCA Holdings, Inc. (HCA) is one of the largest private operators of hospitals and outpatient facilities in the United States. The company earns revenue from inpatient and outpatient care, surgeries, emergency services and ancillary diagnostics across a broad network of acute-care hospitals and ambulatory centres. Scale provides negotiating power with payors and some operational efficiencies, but the business is capital intensive and sensitive to labour costs, regulation and reimbursement changes from Medicare, Medicaid and private insurers. HCA’s performance also ties to volumes for elective procedures and broader economic conditions. Investors often watch occupancy trends, payer mix, margins and leverage when assessing prospects. With a market capitalisation around $101 billion, HCA combines steady demand driven by an ageing population with exposure to regulatory and cost pressures. This is general educational information, not advice; values can fall as well as rise and suitability depends on individual circumstances.
Why It’s Moving
HCA Faces Legal Scrutiny and Earnings Pressure Ahead of Q3 Report
- Pomerantz LLP has launched an investigation into claims on behalf of HCA investors, adding a layer of legal uncertainty to the company's current profile.
- Analysts anticipate a decline in earnings for the quarter ended September 2026, citing that HCA lacks the key ingredients for a likely beat despite higher admissions.
- The outlook remains clouded by rising operational costs and fewer outpatient surgeries, which may offset benefits from increased occupancy and inpatient revenues.
HCA Faces Legal Scrutiny and Earnings Pressure Ahead of Q3 Report
- Pomerantz LLP has launched an investigation into claims on behalf of HCA investors, adding a layer of legal uncertainty to the company's current profile.
- Analysts anticipate a decline in earnings for the quarter ended September 2026, citing that HCA lacks the key ingredients for a likely beat despite higher admissions.
- The outlook remains clouded by rising operational costs and fewer outpatient surgeries, which may offset benefits from increased occupancy and inpatient revenues.
Sixth Month Growth Performance
When is the next earnings date for HCA (HCA)?
HCA Healthcare is scheduled to release its next earnings report on October 27, 2026, before the market opens. This upcoming disclosure will cover the company's financial performance for the third quarter of 2026. The confirmed date aligns with HCA’s historical pattern of reporting results approximately three months after the previous quarter's close.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying HCA's stock, expecting it to reach a higher price of $412.99.
Financial Health
HCA is performing well with strong revenue, profits, and cash flow, indicating good financial health.
Dividend
HCA's low dividend yield of 0.65% indicates limited returns from dividends. If you invested $1000, you would be paid $6.50 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Large Hospital Network
HCA’s national footprint offers scale advantages in purchasing and revenue diversification, though local market dynamics and competition can influence performance.
Demographic Tailwinds
An ageing population supports demand for healthcare services over the long term, but funding and reimbursement policies remain important uncertainties.
Operational Efficiency Focus
Management emphasises cost control and outpatient expansion to improve margins, yet labour costs and capital expenditure needs can pressure cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
